Scarica l'app Stockscreener
6.95
0.00%
0.00
Dopo l'orario di chiusura:
6.95
Ginkgo Bioworks Holdings Inc Borsa (DNA) Ultime notizie
(DNA) Price Dynamics and Execution-Aware Positioning - Stock Traders Daily
BTIG Maintains Ginkgo Bioworks(DNA.US) With Sell Rating, Maintains Target Price $5 - Moomoo
BTIG reiterates Ginkgo Bioworks stock Sell rating at $5 target By Investing.com - Investing.com Nigeria
BTIG reiterates Ginkgo Bioworks stock Sell rating at $5 target - Investing.com
BTIG Reiterates Sell Rating on Ginkgo Bioworks Holdings Inc (DNA) - StreetInsider
Ginkgo Bioworks: Another Pivot, Still No Proof Of Product-Market Fit (NYSE:DNA) - Seeking Alpha
Ginkgo Bioworks (DNA) Declines 4.13% as Shares Approach Critical $6.61 SupportRating Change - siam.in
Ginkgo Bioworks CFO Steven Coen sells $2,302 in stock - Investing.com
Ginkgo Bioworks (DNA) officer to sell 330 shares for taxes after vesting - Stock Titan
Ginkgo Bioworks (NYSE:DNA) Shares Gap UpHere's Why - MarketBeat
Ginkgo Bioworks (NYSE:DNA) Upgraded to Hold at Zacks Research - MarketBeat
Ginkgo Bioworks (NYSE: DNA) insider plans 2,200-share sale - Stock Titan
How Ginkgo Bioworks Holdings Inc. Class A (DNA) Affects Rotational Strategy Timing - Stock Traders Daily
Ginkgo Bioworks (DNA) Slides 6.22% as Shares Approach Key SupportEntry Point Alerts - vinanet.vn
These Analysts Think Ginkgo Bioworks Holdings, Inc.'s (NYSE:DNA) Sales Are Under Threat - Moomoo
Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) Analysts Just Slashed This Year's Revenue Estimates By 22% - simplywall.st
Analysts Offer Insights on Healthcare Companies: Janux Therapeutics Inc (JANX) and Ginkgo Bioworks Holdings (DNA) - The Globe and Mail
Ginkgo Bioworks Holdings, Inc. (DNA) Q2 2026 Earnings ReportResults, Call & Slides - TipRanks
William Blair Maintains Ginkgo Bioworks(DNA.US) With Sell Rating - Moomoo
Ginkgo Bioworks Holdings Inc (DNA) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Ginkgo Bioworks (DNA) Sheds 3.33% as Shares Approach Critical $6.9 SupportStock Buy Zone - vinanet.vn
Kolchinsky Warns Ban on Chinese Biotech Deals Would Hand Pipeline to Novartis - finance.biggo.com
Ginkgo Bioworks (DNA) Short Interest & Short Float | Updated Aug 2026 $DNA - MarketBeat
Ginkgo Bioworks Holdings Number of Employees 2026 | Employee Count & Headcount Data - Revelio Labs
Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) Shares Slammed 36% But Getting In Cheap Might Be Difficult Regardless - 富途牛牛
Ginkgo Bioworks (NYSE:DNA) Stock Rating Upgraded by Wall Street Zen - MarketBeat
Ginkgo Bioworks Q2 Earnings Call Highlights - MarketBeat
DNA Downgraded by TD Cowen -- Price Target Lowered to $9.00 - GuruFocus
TD Cowen Downgrades Ginkgo Bioworks(DNA.US) to Hold Rating, Cuts Target Price to $9 - Moomoo
TD Cowen cuts Ginkgo Bioworks stock rating on growth uncertainty - Investing.com India
TD Cowen Downgrades Ginkgo Bioworks to Hold From Buy, Adjusts Price Target to $9 From $12 - marketscreener.com
TD Cowen cuts Ginkgo Bioworks stock rating on growth uncertainty By Investing.com - Investing.com Australia
TD Cowen Downgrades Ginkgo Bioworks Holdings Inc (DNA) to Hold - StreetInsider
Ginkgo Bioworks Holdings, Inc. Q2 2026 Earnings Call Summary - Yahoo Finance
Ginkgo Bioworks Holdings, Inc. reports results for the quarter ended June 30Earnings Summary - tradingview.com
Ginkgo Bioworks Holdings, Inc. 2Q 2026: Revenue ($46.95M), Net income ($46.71M), EPS ($0.75) — 10-Q Summary - TradingView
Biosecurity sale shapes Ginkgo Bioworks (NYSE: DNA) Q2 2026 results - Stock Titan
Ginkgo Bioworks Holdings, Inc. 2026 Q2ResultsEarnings Call Presentation (NYSE:DNA) 2026-08-06 - Seeking Alpha
Ginkgo Bioworks (NYSE:DNA) Trading Down 9.6%Here's What Happened - MarketBeat
BlackRock, Inc. Buys Ginkgo Bioworks Holdings Inc (DNA) -- Shares Look 32% Overvalued on GF Value - GuruFocus
Earnings call transcript: Ginkgo Bioworks Q2 2026 revenue miss weighs on shares - Investing.com Canada
Ginkgo Bioworks : Q2 2026 Results Presentation - marketscreener.com
Ginkgo Bioworks (NYSE:DNA) Releases Earnings Results, Beats Expectations By $0.15 EPS - MarketBeat
Ginkgo Bioworks (DNA) Stock Falls on Q2 2026 Earnings - Quiver Quantitative
Ginkgo Bioworks Holdings, Inc. (DNA) Q2 FY2026 earnings call transcript - Yahoo Finance
Ginkgo Bioworks reports Q2 2026 revenue $20.2M, GAAP net loss $57.3M, Adjusted EBITDA ($36.3M) - TradingView
Ginkgo Bioworks (NYSE: DNA) posts Q2 loss, wins $47M lab deal - Stock Titan
(DNA) and the Role of Price-Sensitive Allocations - Stock Traders Daily
Ginkgo Bioworks (DNA) Surges Nearly 10% as Biotech Sentiment StrengthensRetail Volume - vinanet.vn
INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Ginkgo Bioworks Holdings, Inc. and Encourages Investors with Losses to Contact the Firm - TMX Newsfile
Ginkgo Bioworks to Review Q2 2026 Performance - The Globe and Mail
Ginkgo Bioworks (DNA.US) will release its earnings report after market close on August 5. - Moomoo
Ginkgo Bioworks (DNA) CEO Jason R. Kelly receives over 300k new RSUs - Stock Titan
Ginkgo Bioworks (NYSE: DNA) plans Q2 2026 results presentation and Q&A - Stock Titan
Ginkgo Bioworks (NYSE: DNA) awards RSUs to 10% owner - Stock Titan
Ginkgo Bioworks (DNA) Edges Higher: Holding Above Key Support After 1.1% GainFRAMA Signal - Vinanet
Ginkgo Bioworks Holdings Inc (DNA) Balance Sheet - TradingKey
Ginkgo Bioworks Holdings Inc (DNA) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
DNA|Ginkgo Bioworks Holdings Inc|Price:7.445|Chg%:+0.085 - TradingKey
Ginkgo Bioworks Holdings Inc (DNA) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Ginkgo Bioworks Holdings Inc (DNA) Income Statement - TradingKey
0.86%
0.31%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):